Selzentry and Invirase drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Selzentry (maraviroc) and Invirase (saquinavir mesylate). Common drug interactions include anhedonia among females and emotional distress among males.

The phase IV clinical study analyzes what interactions people have when they take Selzentry and Invirase. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Selzentry?

Selzentry has active ingredients of maraviroc. It is often used in hiv infection. eHealthMe is studying from 710 Selzentry users. Check the latest studies of Selzentry.

What is Invirase?

Invirase has active ingredients of saquinavir mesylate. eHealthMe is studying from 2,690 Invirase users. Check the latest studies of Invirase.



On Jul, 19, 2026

19 people who take Selzentry and Invirase together, and have interactions are studied.

Selzentry and Invirase drug interactions.

What are the common drug interactions of Selzentry and Invirase, by gender? *:

female:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Osteopenia (a condition where bone mineral density is lower than normal)
  5. Pain
  6. Asthenia (weakness)
  7. Blood pressure fluctuation
  8. Bone loss
  9. Chronic kidney disease
  10. Decreased appetite

male:

  1. Emotional distress
  2. Pain
  3. Hip fracture
  4. Wrist fracture
  5. Back pain
  6. Facet joint syndrome (problem with movement of the facet joints of the spine)
  7. Gait disturbance
  8. Intervertebral disc degeneration (spinal disc degeneration)
  9. Intervertebral disc space narrowing (spinal disc space narrowing)
  10. Lumbar vertebral fracture

What are the common drug interactions of Selzentry and Invirase, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Back pain
  4. Bone density decreased
  5. Depression
  6. Emotional distress
  7. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  8. Fatigue (feeling of tiredness)
  9. Glycosuria (excretion of glucose into the urine)
  10. Osteopenia (a condition where bone mineral density is lower than normal)

50-59:

  1. Emotional distress
  2. Pain
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Bone density decreased
  6. Chronic kidney disease
  7. Facet joint syndrome (problem with movement of the facet joints of the spine)
  8. Gait disturbance
  9. Intervertebral disc degeneration (spinal disc degeneration)
  10. Intervertebral disc space narrowing (spinal disc space narrowing)

60+:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Osteopenia (a condition where bone mineral density is lower than normal)
  4. Pain
  5. Renal impairment (severely reduced kidney function)
  6. Syncope (loss of consciousness with an inability to maintain postural tone)
  7. Anaemia (lack of blood)
  8. Atrioventricular block (heart block)
  9. Cataract (clouding of the lens inside the eye)
  10. Pneumonia

What are the existing conditions these people have? *

  1. Stress And Anxiety: 6 people, 31.58%
  2. Depression: 6 people, 31.58%
  3. Pain: 6 people, 31.58%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 31.58%
  5. Viral Infection: 4 people, 21.05%
  6. High Blood Cholesterol: 4 people, 21.05%
  7. Bone Pain: 4 people, 21.05%
  8. Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 21.05%
  9. Nausea (feeling of having an urge to vomit): 4 people, 21.05%
  10. Quit Smoking: 4 people, 21.05%

* Approximation only. Some reports may have incomplete information.

Do you take Selzentry and Invirase?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Selzentry and Invirase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Selzentry:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Invirase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Selzentry and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Invirase and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on maraviroc and saquinavir mesylate (the active ingredients of Selzentry and Invirase, respectively), and Selzentry and Invirase (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: